Literature DB >> 30977057

Drug-Nutrition Interactions and the Brain: It's Not All in Your Head.

Joseph I Boullata1,2.   

Abstract

PURPOSE OF REVIEW: The interactions between nutrition and medication can be numerous with potential impact on health outcomes. Several subtypes of drug-nutrition interactions exist. Each of these interaction subtypes may influence patients receiving medication for neurologic disorders. After defining drug-nutrition interactions, this review will describe the various types using a handful of widely used central nervous system agents as examples. RECENT
FINDINGS: Medication may be the object of interactions perpetrated by a specific meal, a food component, a nutrient, or nutrition status thereby altering drug disposition and clinical effect. On the other hand, drugs can influence nutrition status generally or the status of specific nutrients by any number of mechanisms. Individuals using medication for neurologic disorders are at risk for drug-nutrition interactions of all types.

Entities:  

Keywords:  Drug; Food; Interaction; Medication; Nutrient; Nutrition

Year:  2019        PMID: 30977057     DOI: 10.1007/s13668-019-0273-2

Source DB:  PubMed          Journal:  Curr Nutr Rep        ISSN: 2161-3311


  67 in total

1.  Effects of cysteine on the pharmacokinetics of intravenous phenytoin in rats with protein-calorie malnutrition.

Authors:  Y G Kim; M K Cho; J W Kwon; S G Kim; S J Chung; C K Shim; M G Lee
Journal:  Int J Pharm       Date:  2001-10-23       Impact factor: 5.875

Review 2.  Drug-nutrient interactions: a broad view with implications for practice.

Authors:  Joseph I Boullata; Lauren M Hudson
Journal:  J Acad Nutr Diet       Date:  2012-02-07       Impact factor: 4.910

3.  Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy.

Authors:  P C Souverein; D J Webb; J G Weil; T P Van Staa; A C G Egberts
Journal:  Neurology       Date:  2006-05-09       Impact factor: 9.910

Review 4.  Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults.

Authors:  Manjunath P Pai
Journal:  Pharmacotherapy       Date:  2012-06-18       Impact factor: 4.705

5.  Carnitine levels in valproic acid-treated psychiatric patients: a cross-sectional study.

Authors:  Francisco A Moreno; Helen Macey; Brian Schreiber
Journal:  J Clin Psychiatry       Date:  2005-05       Impact factor: 4.384

6.  Carbamazepine pharmacokinetics in obese and lean subjects.

Authors:  Y Caraco; E Zylber-Katz; E M Berry; M Levy
Journal:  Ann Pharmacother       Date:  1995-09       Impact factor: 3.154

7.  The effect of valproic acid on plasma carnitine levels.

Authors:  G Opala; S Winter; C Vance; H Vance; H T Hutchison; L S Linn
Journal:  Am J Dis Child       Date:  1991-09

8.  Trends in Prescription Drug Use Among Adults in the United States From 1999-2012.

Authors:  Elizabeth D Kantor; Colin D Rehm; Jennifer S Haas; Andrew T Chan; Edward L Giovannucci
Journal:  JAMA       Date:  2015-11-03       Impact factor: 56.272

9.  The effect of B-vitamins on hyperhomocysteinemia in patients on antiepileptic drugs.

Authors:  Terje Apeland; Mohammad A Mansoor; Kristina Pentieva; Helene McNulty; Ingebjørg Seljeflot; Roald E Strandjord
Journal:  Epilepsy Res       Date:  2002-10       Impact factor: 3.045

10.  Folic acid improves phenytoin pharmacokinetics.

Authors:  M J Berg; P J Stumbo; C A Chenard; R W Fincham; P J Schneider; D D Schottelius
Journal:  J Am Diet Assoc       Date:  1995-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.